Beta
Today
Capital & Financial MarketsLeadership & GovernanceRegulatory & Legal 3 Oct 2026

Gerresheimer delays 2025 results to June, faces SDAX exclusion

Gerresheimer has postponed publication of its audited 2025 annual and consolidated financial statements from 31 March to June, citing ongoing external audit probes into business transactions in 2024 and 2025. The delay is set to trigger the packaging maker's removal from Deutsche Boerse's SDAX index, and Germany's BaFin has opened an audit of interim statements covering 1 December 2024 to 31 May 2025, citing concrete evidence of accounting violations. Q1 results, originally due 16 April, and the annual general meeting, set for 3 June, have also been postponed.

Why this mattersProlonged accounting probes forcing a results delay and index exclusion raise financing and governance risk for a core pharma and medical device packaging supplier.

  • Audited 2025 annual and consolidated results, previously due by 31 March, postponed to June
  • The delay is set to trigger Gerresheimer's removal from Deutsche Boerse's SDAX index
  • BaFin has opened an audit of interim statements from 1 December 2024 to 31 May 2025, citing concrete evidence of accounting violations
  • Q1 results, originally scheduled for 16 April, postponed with no new date given
  • Annual general meeting, originally set for 3 June, postponed
  • Gerresheimer shares down about 28% year-to-date, after a 61% decline in 2025
Gerresheimer
Sources stockopedia.com
Relevant to you?

Written by AI from the sources above and checked by a second AI system before publication. No human wrote or edited this story. How it is made.

Updates

  • 2026-09-29 · Edited before publication: The excerpt reports that BaFin has opened an audit of Gerresheimer's interim statements citing concrete evidence of accounting violations. That is at least as material as the index exclusion and was omitted. Added to summary and key facts.